FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890747679> ?p ?o ?g. }

• W2890747679 abstract "The aim of the present study was to investigate the activities of novel synthetic epidermal growth factor receptor (EGFR) inhibitors (ZINC05463076, ZINC2102846 and ZINC19901103) against prostate tumors, in vitro models and investigate the potential underlying mechanisms. A panel of prostate tumor cell lines (LNCaP, DU-145, PC-3 and LNCaP-AI cells) were used to evaluate antitumor activity of ZINC05463076, ZINC2102846, and ZINC19901103 in vitro. Cell growth and clonal formation were determined by MTT assay and Soft agar colony formation assay, respectively. An EGFR kinase assay following treatment of the compounds was performed by ELISA. Cell cycle-regulating proteins, including cyclin-dependent kinase (CDK)1, CKD2, CKD4 and inhibitory effects of these compounds on downstream signaling were analyzed by western blotting. Flow cytometry was performed to investigate apoptosis and cell cycle phases of the treated cells. It was revealed that all compounds synthesized in the present study demonstrated significant EGFR inhibition abilities, compared with approved EGFR inhibitor drug gefitinib. Treatment of LNCaP, DU-145, PC3 and LNCaP-AI cells with these compounds revealed cell proliferation inhibition and colony formation suppression dose-dependently in vitro. The agents impaired phosphorylation of EGFR and extracellular signal-regulated kinase 1/2 and suppressed their downstream signaling. In addition, these novel synthetic agents decreased the expression level of survivin, which may induce G1 cell cycle phase arrest and cell apoptosis in PCa cells subsequently. Collectively, ZINC05463076, ZINC2102846 and ZINC19901103 exhibited significant antitumor activity in human prostate tumors in vitro, by inhibiting EGFR and promoting apoptosis, which suggested a rationale for clinical development in prostate tumor therapy." @default.
• W2890747679 created "2018-09-27" @default.
• W2890747679 creator A5003689755 @default.
• W2890747679 creator A5004092065 @default.
• W2890747679 creator A5025226017 @default.
• W2890747679 creator A5044890447 @default.
• W2890747679 creator A5057641523 @default.
• W2890747679 creator A5060696709 @default.
• W2890747679 creator A5065843964 @default.
• W2890747679 creator A5069417259 @default.
• W2890747679 creator A5070171249 @default.
• W2890747679 creator A5075092197 @default.
• W2890747679 date "2018-09-14" @default.
• W2890747679 modified "2023-10-17" @default.
• W2890747679 title "Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells" @default.
• W2890747679 cites W1144121322 @default.
• W2890747679 cites W1584518118 @default.
• W2890747679 cites W1636699277 @default.
• W2890747679 cites W1653739410 @default.
• W2890747679 cites W1973342943 @default.
• W2890747679 cites W1973453862 @default.
• W2890747679 cites W1984789858 @default.
• W2890747679 cites W1993675569 @default.
• W2890747679 cites W2001577706 @default.
• W2890747679 cites W2003793248 @default.
• W2890747679 cites W2026982091 @default.
• W2890747679 cites W2040564571 @default.
• W2890747679 cites W2089485939 @default.
• W2890747679 cites W2102174623 @default.
• W2890747679 cites W2107277218 @default.
• W2890747679 cites W2107506448 @default.
• W2890747679 cites W2127760066 @default.
• W2890747679 cites W2131194887 @default.
• W2890747679 cites W2132879101 @default.
• W2890747679 cites W2141158380 @default.
• W2890747679 cites W2156702383 @default.
• W2890747679 cites W2158607622 @default.
• W2890747679 cites W2163148645 @default.
• W2890747679 cites W2169937670 @default.
• W2890747679 cites W2179425537 @default.
• W2890747679 cites W2192080449 @default.
• W2890747679 cites W2255138050 @default.
• W2890747679 cites W2275101974 @default.
• W2890747679 cites W2288903023 @default.
• W2890747679 cites W2316996536 @default.
• W2890747679 cites W2322898660 @default.
• W2890747679 cites W2328671688 @default.
• W2890747679 cites W2337327455 @default.
• W2890747679 cites W2342937470 @default.
• W2890747679 cites W2346316361 @default.
• W2890747679 cites W2462022051 @default.
• W2890747679 cites W2622197960 @default.
• W2890747679 cites W2733754746 @default.
• W2890747679 cites W370614919 @default.
• W2890747679 doi "https://doi.org/10.3892/ol.2018.9438" @default.
• W2890747679 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6202546" @default.
• W2890747679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30405791" @default.
• W2890747679 hasPublicationYear "2018" @default.
• W2890747679 type Work @default.
• W2890747679 sameAs 2890747679 @default.
• W2890747679 citedByCount "2" @default.
• W2890747679 countsByYear W28907476792021 @default.
• W2890747679 countsByYear W28907476792022 @default.
• W2890747679 crossrefType "journal-article" @default.
• W2890747679 hasAuthorship W2890747679A5003689755 @default.
• W2890747679 hasAuthorship W2890747679A5004092065 @default.
• W2890747679 hasAuthorship W2890747679A5025226017 @default.
• W2890747679 hasAuthorship W2890747679A5044890447 @default.
• W2890747679 hasAuthorship W2890747679A5057641523 @default.
• W2890747679 hasAuthorship W2890747679A5060696709 @default.
• W2890747679 hasAuthorship W2890747679A5065843964 @default.
• W2890747679 hasAuthorship W2890747679A5069417259 @default.
• W2890747679 hasAuthorship W2890747679A5070171249 @default.
• W2890747679 hasAuthorship W2890747679A5075092197 @default.
• W2890747679 hasBestOaLocation W28907476791 @default.
• W2890747679 hasConcept C121608353 @default.
• W2890747679 hasConcept C170493617 @default.
• W2890747679 hasConcept C190283241 @default.
• W2890747679 hasConcept C2776362946 @default.
• W2890747679 hasConcept C2779438470 @default.
• W2890747679 hasConcept C2779723316 @default.
• W2890747679 hasConcept C2781018059 @default.
• W2890747679 hasConcept C29537977 @default.
• W2890747679 hasConcept C47170353 @default.
• W2890747679 hasConcept C502942594 @default.
• W2890747679 hasConcept C53227056 @default.
• W2890747679 hasConcept C54355233 @default.
• W2890747679 hasConcept C55493867 @default.
• W2890747679 hasConcept C62112901 @default.
• W2890747679 hasConcept C81885089 @default.
• W2890747679 hasConcept C86803240 @default.
• W2890747679 hasConcept C96232424 @default.
• W2890747679 hasConceptScore W2890747679C121608353 @default.
• W2890747679 hasConceptScore W2890747679C170493617 @default.
• W2890747679 hasConceptScore W2890747679C190283241 @default.
• W2890747679 hasConceptScore W2890747679C2776362946 @default.
• W2890747679 hasConceptScore W2890747679C2779438470 @default.
• W2890747679 hasConceptScore W2890747679C2779723316 @default.
• W2890747679 hasConceptScore W2890747679C2781018059 @default.
• W2890747679 hasConceptScore W2890747679C29537977 @default.

• next